Inspection, AERs Prompt Hyland's Teething Tablets Recall
This article was originally published in The Tan Sheet
Executive Summary
Enforcement on Standard Homeopathic Co.'s Hyland's Teething Tablets marks FDA's second action in 18 months against a major U.S. homeopathic firm.
You may also be interested in...
Homeopathy Gains From J&J Recalls As Consumers, Retailers Seek Alternatives
Johnson & Johnson's OTC drug recalls are driving interest in homeopathic remedies and other alternative health products, experts and stakeholders say.
Safety, Convenience Propel Homeopathic Firms' Push For Market Share
Homeopathic marketers such as Enzymatic Therapy and Hyland's are highlighting their remedies' safety records -- particularly with cold products for children -- to make alternative medicine more of a household term in the competition for consumer's health care spending
Zicam Lawsuits Multiply, But Matrixx Is Confident History Will Repeat Itself
Matrixx Initiatives braces for new lawsuits alleging the firm's Zicam intranasal products cause anosmia - a loss of the sense of smell - following FDA's warning letter to the firm and consumer alert